ToleriMab

N/A

Report date: 2023/01/14 14:15:20

Base Information

Drug NameToleriMab
Drug Alias Nameanti-B7.1 Mab + anti-B7.2 Mab
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunosuppressants
TargetsNot applicable
Therapy Area/IndicationsRejection of organ transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInnogenetics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnogenetics
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantation

Other Information

ATC CodeN/A
Related LinksN/A